ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Advocacy & Public Policy

Legislative Action Center

Take Action to Increase Access to Immunosuppressive Medications

We need your help to ensure that kidney transplant patients are able to access life-saving immunosuppressive medications.

Congress has introduced the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534/S. 3353), bipartisan legislation that would remove Medicare's three-year limit for coverage of immunosuppressive drugs.

According to a pre-pandemic HHS report, hundreds of kidney transplant patients lose their transplant due to an inability to afford immunosuppressive medication. This is not only costly to the health of the patient, but also to Medicare as the patient returns to dialysis. A recent analysis by the non-partisan Congressional Budget Office found that extending coverage of immunosuppressive drugs would save Medicare $70 million over a period of 10 years.

Further, COVID-19 poses unique challenges to people with kidney diseases, and many kidney transplant patients may face additional challenges returning to work due to their immunosuppressed status. It is critical that these patients are able to afford their medications and maintain the health of their transplant.

Your legislators need to hear from you as a constituent. Urge them to pass the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act, which will save lives and taxpayer dollars.

A pre-composed email to your Representative and Senators is available by filling out the form below.

Thank you for your help in advocating to improve the lives of the more than 37 million Americans with kidney diseases.